Announce Date | 02/04/2025 |
EPS Normalized Actual | $1.09 (Beat by $0.01) |
EPS GAAP Actual | $1.09 (Beat by $0.01) |
Revenue Actual | $7.658B |
Revenue Surprise | Beat by $7658M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 9.91 | 8.65 | 8.19782 | 12.31902 | 6 |
Dec 2026 | 4.91195 | 17.45 | 3.02761 | 7.41 | 9 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.3 | 0.3 | 7.658B | 19.46% | 7658M |
FQ3 2024 (Sep 2024) | 0.48 | 0.48 | 6.819B | 21.41% | 6819M |
FQ2 2024 (Jun 2024) | 0.16 | 0.16 | 5.835B | 100% | 5835M |
FQ1 2024 (Mar 2024) | 0.0761 | 0.0761 | 5.473B | 100% | 5473M |
FQ4 2023 (Dec 2023) | 0.41 | 0.41 | 6.168B | 9.23% | 6168M |
FQ3 2023 (Jul 2023) | 0.0167 | 0.0167 | 5.359B | -3.84% | 5359M |
FQ4 2022 (Dec 2022) | 0.013 | 0.013 | 5.599B | 100% | 5599M |
FQ3 2022 (Sep 2022) | 0.041 | 0.041 | 5.565B | 100% | 5565M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.3687 | -- | 2.19731 | 2.4777 | 11 |
FQ3 2027 (Sep 2027) | 2.07323 | -- | 1.92322 | 2.16863 | 22 |
FQ2 2027 (Jun 2027) | 1.84831 | -- | 1.71458 | 1.93336 | 11 |
FQ1 2027 (Mar 2027) | 1.65192 | -- | 1.5324 | 1.72793 | 22 |
FQ4 2026 (Dec 2026) | 2.1162 | -- | 2.04998 | 2.22154 | 18 |
FQ3 2026 (Sep 2026) | 1.66917 | -- | 1.5484 | 1.74598 | 11 |
FQ2 2026 (Jun 2026) | 1.44007 | -- | 1.33587 | 1.50634 | 18 |
FQ1 2026 (Mar 2026) | 1.48269 | -- | 1.43629 | 1.5565 | 20 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 14.03B | -- | 13.25B | 14.53B | 12 |
FQ3 2027 (Sep 2027) | 12.9B | -- | 12.19B | 13.36B | 23 |
FQ2 2027 (Jun 2027) | 11.68B | -- | 11.03B | 12.09B | 12 |
FQ1 2027 (Mar 2027) | 10.86B | -- | 10.26B | 11.25B | 23 |
FQ4 2026 (Dec 2026) | 11.15B | -- | 10.88B | 11.58B | 19 |
FQ3 2026 (Sep 2026) | 9.95B | -- | 9.4B | 10.3B | 12 |
FQ2 2026 (Jun 2026) | 9.09B | -- | 8.58B | 9.41B | 19 |
FQ1 2026 (Mar 2026) | 8.9B | -- | 8.68B | 9.24B | 21 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.3 | 0.3 | 100% | |
FQ3 2024 (Sep 2024) | 0.48 | 0.48 | 100% | |
FQ2 2024 (Jun 2024) | 0.16 | 0.16 | 100% | |
FQ1 2024 (Mar 2024) | 0.0761 | 0.0761 | 100% | |
FQ4 2023 (Dec 2023) | 0.41 | 0.41 | 100% | |
FQ3 2023 (Jul 2023) | 0.0167 | 0.0167 | 100% | |
FQ4 2022 (Dec 2022) | 0.013 | 0.013 | 100% | |
FQ3 2022 (Sep 2022) | 0.041 | 0.041 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $7.66B | $7658M | 100% |
FQ3 2024 (Sep 2024) | $0B | $6.82B | $6819M | 100% |
FQ2 2024 (Jun 2024) | $0B | $5.84B | $5835M | 100% |
FQ1 2024 (Mar 2024) | $0B | $5.47B | $5473M | 100% |
FQ4 2023 (Dec 2023) | $0B | $6.17B | $6168M | 100% |
FQ3 2023 (Jul 2023) | $0B | $5.36B | $5359M | 100% |
FQ4 2022 (Dec 2022) | $0B | $5.6B | $5599M | 100% |
FQ3 2022 (Sep 2022) | $0B | $5.57B | $5565M | 100% |